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he Rho GTPase and Fyn tyrosine kinase have been
implicated previously in positive control of keratinocyte
cell–cell adhesion. Here, we show that Rho and Fyn
operate along the same signaling pathway. Endogenous
Rho activity increases in differentiating keratinocytes and is
required for both Fyn kinase activation and increased tyrosine
phosphorylation of 
 
 
 
- and 
 
 
 
-catenin, which is associated
with the establishment of keratinocyte cell–cell adhesion.
Conversely, expression of constitutive active Rho is sufﬁcient
to promote cell–cell adhesion through a tyrosine kinase-
and Fyn-dependent mechanism, trigger Fyn kinase activation,
and induce tyrosine phosphorylation of 
 
 
 
- and 
 
 
 
-catenin
T
 
and p120
 
ctn
 
. The positive effects of activated Rho on cell–
cell adhesion are not induced by an activated Rho mutant
with defective binding to the serine/threonine PRK2/PKN
kinases. Endogenous PRK2 kinase activity increases with
keratinocyte differentiation, and, like activated Rho, in-
creased PRK2 activity promotes keratinocyte cell–cell
adhesion and induces tyrosine phosphorylation of 
 
 
 
- and
 
 
 
-catenin and Fyn kinase activation. Thus, these ﬁndings
reveal a novel role of Fyn as a downstream mediator of
Rho in control of keratinocyte cell–cell adhesion and
implicate the PRK2 kinase, a direct Rho effector, as a link
between Rho and Fyn activation.
 
Introduction
 
Cadherin-mediated cell–cell adhesion plays a crucial func-
tion in establishment and maintenance of organized tissues.
Although the extracellular domain of cadherins is essential
for connecting neighboring cells through calcium-dependent
homophilic interactions, the cadherin intracellular domain is
crucial for regulating the strength of cell–cell adhesion. This
latter aspect of cadherin function is regulated by a complex
cross-talk of intracellular signaling pathways (Provost and
Rimm, 1999; Gumbiner, 2000). The epidermis provides an
excellent experimental system to investigate cell–cell adhesion
control in stratified epithelia. The continuous vertical differ-
entiation program of this tissue involves highly dynamic
changes in cell–cell adhesion (O’Keefe et al., 1987; Lewis et
al., 1994; Tao et al., 1996). Two major families of signal-
ing proteins have been implicated in positive regulation of
E-cadherin–dependent cell–cell adhesion in keratinocytes:
Rho-like GTPases (Braga et al., 1997) and Fyn/Src tyrosine
kinases (Calautti et al., 1998).
Rho-like GTPases play an important role as regulators of
cell–cell adhesion in a manner which varies substantially de-
pending on cell type and cellular context (Hall, 1998). In
keratinocytes, both Rac and Rho activities are required for
cell–cell junction formation (Braga et al., 1997). In these
cells, Rac has been implicated upstream of Rho in remodeling
of cortical actin, whereas Rho appears required for cadherin
clustering at the cell membrane via an actin-independent
mechanism (Braga et al., 1997). The downstream mecha-
nisms responsible for Rho-mediated cell–cell adhesion and
the direct Rho effectors involved have not been defined.
Tyrosine phosphorylation of adherens junction and des-
mosome components have also been implicated in cell–cell
adhesion control (Provost and Rimm, 1999; Gumbiner,
2000). Mitogenic growth factor stimulation of receptor ty-
rosine kinases frequently causes disassembly of adherens
junctions together with tyrosine phosphorylation of adher-
ens junction components such as 
 
 
 
- and 
 
 
 
-catenin and
p120
 
ctn
 
 (Kanner et al., 1991; Reynolds et al., 1994; Shibamoto
et al., 1994, 1995). Similar effects are induced by expression
of oncogenic Src kinase (Behrens et al., 1993; Hamaguchi et
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al., 1993; Calautti et al., 1998) even if in this case disassem-
bly of adherens junctions may be independent of 
 
 
 
-catenin
phosphorylation and involve tyrosine phosphorylation of
other molecules (Takeda et al., 1995). In contrast to the ef-
fects of growth factor receptors or oncogenic Src, endoge-
nous tyrosine kinases of the Src family, and Fyn in particu-
lar, play a positive role in cell–cell junction formation in
keratinocytes both in vitro and in vivo (Calautti et al.,
1998). In fact, the establishment of keratinocyte cell–cell ad-
hesions is associated with increased tyrosine phosphorylation
of 
 
 
 
- and 
 
 
 
-catenin and p120
 
ctn
 
, and adherens junction for-
mation is impaired in cells treated with tyrosine kinase in-
hibitors or lacking Fyn, either alone or in combination with
Src (Calautti et al., 1998).
Thus, in keratinocytes both small GTPases of the Rho
family and Fyn/Src tyrosine kinases have been implicated in-
dependently in positive regulation of cell–cell adhesion.
Here, we show that these two signaling pathways are func-
tionally and biochemically connected and point to the
PRK2 kinase, a direct Rho effector (Bishop and Hall, 2000),
as a link between Rho and Fyn activation.
 
Results
 
Endogenous Rho activity increases with keratinocyte 
differentiation and is necessary for the establishment 
of cell–cell adhesion and underlying tyrosine 
phosphorylation events
 
Exposure of mouse primary keratinocytes to increased ex-
tracellular calcium concentrations provides a well-defined
model for the switch between keratinocyte growth and dif-
ferentiation (Dotto, 1999). To determine whether endoge-
nous Rho activity is regulated during this process, primary
keratinocytes under basal conditions and at various times of
Figure 1. Endogenous Rho activity increases in calcium-induced keratinocyte differentiation. (A) Total cell extracts from mouse primary 
keratinocytes under low calcium conditions and at various times of calcium exposure were incubated with beads coupled to the Rho-binding 
domain of rhotekin, which binds specifically to activated Rho. Pull-down assays were analyzed by 12.5% SDS-PAGE and immunoblotting 
with antibodies against RhoA (top), alongside corresponding total cell extracts, for normalization of total RhoA protein levels (bottom). The 
results of two independent experiments are shown. (B) Densitometric scanning of the autoradiographs was used to determine relative levels 
of RhoA activation versus protein amounts. Average Rho activation from three independent experiments, including the ones shown in A, was 
calculated. Bars refer to value variation among experiments. (C) Keratinocytes under low calcium conditions and at 2 and 9 h of high calcium 
exposure were fixed in 4% paraformaldehyde and processed for immunofluorescence with anti–Rho A polyclonal antibodies and FITC-conjugated 
secondaries. Samples were analyzed by confocal microscopy using the same light exposure and image capture conditions. Arrows point to 
areas of cell–cell contacts in calcium-treated keratinocytes with detectable Rho-specific signal. Bar, 20  m. 
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calcium exposure (2 mM) were analyzed by pull-down assay
with the Rho-binding domain of rhotekin, which specifi-
cally binds the GTP-bound activated form of Rho (Ren et
al., 1999). Rho activity was found to be induced by 1 h of
calcium treatment with a further progressive increase up to
24 h (Fig. 1, A and B). In parallel, immunofluorescence
analysis revealed that a fraction of Rho becomes localized to
cell–cell contacts in calcium-treated keratinocytes (Fig. 1 C).
To determine whether endogenous Rho activity is required
for calcium-induced cell–cell adhesion and underlying ty-
rosine phosphorylation events (Calautti et al., 1998), primary
keratinocytes were pretreated with C3 exotoxin, a specific
Rho inhibitor (Boquet, 1999), and subsequently treated with
calcium for 9 h or maintained under low calcium conditions.
Cells were stained with antibodies against phosphotyrosine
and E-cadherin. Although calcium treatment of control kera-
tinocytes resulted in the expected colocalization of E-cadherin
and tyrosine phosphorylated proteins at cell–cell borders (Fig.
2, top), this was impaired significantly in the C3-treated ke-
ratinocytes (Fig. 2, bottom).
For direct biochemical determinations, C3-treated and
control keratinocytes were processed for immunoprecipita-
tion with E-cadherin antibodies followed by sequential im-
munoblotting with antibodies against phosphotyrosine and
 
 
 
- and 
 
 
 
-catenin. High calcium exposure induced the ex-
pected tyrosine-phosphorylation of 
 
 
 
- and 
 
 
 
-catenin in con-
Figure 2. Endogenous Rho activity is 
required for recruitment of E-cadherin 
and tyrosine-phosphorylated proteins at 
cell–cell borders. Keratinocytes were 
pretreated with a GST-C3 fusion protein 
(bottom) or GST control (top) for 1.5 h 
and either exposed to 2 mM CaCl2 (High 
Ca
2 ) for 9 h or kept in medium at low 
calcium concentrations (0.05 mM) (Low 
Ca
2 ). Cells were briefly preextracted in 
0.2% Triton CSK buffer before paraform-
aldehyde fixation and double stained 
with E-cadherin–specific monoclonal 
antibodies followed by Texas red–
conjugated secondary antibodies (red) 
and with FITC-conjugated antiphospho-
tyrosine antibodies (green). A similar 
pattern of staining was obtained without 
preextraction procedure. Samples were 
analyzed by confocal microscopy using 
same light exposure and image capture 
conditions, and green and red images 
(small panels) were superimposed; sites 
of overlapping staining are visualized as yellow (large panels). Each image is the projection of eight focal planes spanning the whole depth of 
the culture (0.8  m between individual plans). Note that some cell–cell borders stain only weakly with antiphosphotyrosine antibodies. These 
correspond to immature borders at the zipper stage as can be visualized at higher magnification. Bar: (large panels) 15  m; (small panels) 33 
 m. Similar results were obtained in two other experiments.
Figure 3. Endogenous Rho activity is 
required for tyrosine phosphorylation of 
 - and  -catenin in response to increased 
extracellular calcium. (A) Keratinocytes 
were pretreated for 1.5 h with either 
GST-C3 ( ) or GST control proteins ( ) 
and exposed to 2 mM CaCl2 for 9 h or 
maintained under low calcium condi-
tions (0). Cell lysates were immunopre-
cipitated with anti–E-cadherin antibodies 
followed by immunoblotting with anti-
bodies against phosphotyrosine or 
 - and  -catenin as indicated. (B) Kerati-
nocytes in low calcium medium were 
serum-starved for 18 h and then pre-
treated for 1.5 h with either GST-C3 ( ) 
or GST proteins ( ). Cells were stimulated 
for 10 min with EGF at the indicated 
concentrations followed by immunopre-
cipitation with antibodies against the 
EGF receptor (EGFR) and immunoblot-
ting with the same antibodies or antibod-
ies against phosphotyrosine as indicated. (C) Keratinocytes were treated as in B followed by immunoprecipitation with antibodies against SHC and 
immunoblotting with antiphosphotyrosine antibodies. The position of the p46 and p52 isoforms of SHC and of the EGF receptor are indicated. 
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trol cells, whereas C3 treatment almost completely blocked
this response (Fig. 3 A). The C3 inhibition was specific for
the calcium-induced tyrosine phosphorylation events, since
EGF-induced autophosphorylation of the EGF receptor and
phosphorylation of its substrate SHC was not impaired by
C3-treatment (Fig. 3, B and C).
 
Activated Rho promotes cell–cell adhesion in a 
tyrosine kinase-dependent manner
 
The above experiments indicated that endogenous Rho func-
tion is required for the establishment of cell–cell adhesion and
associated tyrosine phosphorylation events. To test whether
increased Rho activity promotes cell–cell adhesion in a ty-
rosine phosphorylation-dependent manner, cells were infected
with an adenovirus expressing a constitutively active RhoV14
mutant. Consistent with calcium providing the initial trigger
for adherens junction formation (O’Keefe et al., 1987),
RhoV14 expression in keratinocytes under low calcium con-
ditions failed to induce cell–cell junctions as assessed by im-
munofluorescence with anti–E-cadherin antibodies (Fig. 4, A
and B). However, upon high calcium exposure formation of
mature E-cadherin junctions was significantly anticipated by
RhoV14 expression. In fact, RhoV14-expressing keratinocytes
showed strong continuous E-cadherin staining at cell–cell
borders by 2 h of calcium exposure, whereas control cells
showed only the typical zipper-like structures characteristic of
immature adherens junctions (Calautti et al., 1998; Va-
sioukhin et al., 2000) (Fig. 4, C and D). Levels of E-cadherin,
 
 
 
- and 
 
 
 
-catenin, and p120
 
ctn
 
 were not increased by RhoV14
expression (unpublished data). In a time course of cell–cell
junction formation, we showed previously that in calcium-
treated keratinocytes the transition from the immature zipper-
like structures to fully formed cell–cell junctions can be sup-
pressed by tyrosine kinase inhibition (Calautti et al., 1998).
Similarly, the “maturation” effect of RhoV14 expression on
cell–cell junction formation was blocked by treatment with
the tyrosine kinase inhibitor Genistein. Both control and
Rho-expressing cells were arrested by this compound at the
zipper-like stage at 2 h of calcium treatment and at later times
(Fig. 4, E and F; unpublished data).
Figure 4. Constitutively active Rho promotes keratinocyte cell–cell 
adhesion by a tyrosine kinase-dependent mechanism. Keratinocytes 
were infected with a control adenovirus expressing the GFP and 
 -gal proteins (AdGFP– -gal) or an adenovirus expressing a consti-
tutively active RhoA mutant together with GFP (AdRhoV14). Cells 
were kept in low calcium medium (0) or exposed to high calcium 
for the last 2 h (2 h) before termination of the experiment (48 h after 
infection). Parallel experiments were performed with cells pretreated 
with the tyrosine kinase inhibitor Genistein (100  M) for 1 h before 
calcium exposure (2 h   Gen). 48 h after infection, samples were 
briefly preextracted with 0.2% Triton CSK buffer, fixed in para-
formaldehyde, and stained with E-cadherin–specific antibodies 
followed by Texas red–conjugated secondary antibodies. The 
higher E-cadherin signal in RhoV14-expressing cells is due to 
increased association of E-cadherin with Triton-insoluble cell–cell 
adhesion structures, since RhoV14 expression causes no increase in 
E-cadherin expression levels (unpublished data). Samples were 
analyzed by confocal microscopy using the same light exposure 
and image capture conditions. Images result from the projection 
of eight focal plans. Similar results were obtained in three other 
experiments. Bar, 15  m.
Figure 5. Quantitative measurement of keratinocyte 
cell–cell adhesion as a function of RhoV14 expression 
and tyrosine phosphorylation. (A) Triplicate samples 
of primary keratinocytes infected with control 
(AdGFP– -gal; white bars) or RhoV14-expressing 
(AdRhoV14; black bars) adenoviruses were kept under 
low calcium conditions (Low Ca
2 ) or treated with 
calcium for 3 or 9 h. Data are expressed as the per-
centage of single cells released by mechanical disrup-
tion after dispase treatment versus total number of 
cells recovered after subsequent treatment of the same 
samples with trypsin. The difference in single cell 
release from the RhoV14-expressing keratinocytes 
versus same cells treated with Genistein was found to 
be statistically significant (P   0.004) as assessed by 
Kruskall-Wallis test. (B) A similar assay was performed 
with adenovirus-infected keratinocytes under low calcium conditions or incubated with calcium for 3 h in the absence or the presence of 
Genistein (100  M), PP1 (5  M), or AG1478 (5  M). Inhibitors were added to the medium 12 h after adenovirus infection, and cells were 
kept in low calcium medium or exposed to 2 mM CaCl2 for the last 3 h before termination of the experiment (48 h after infection). 
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We previously developed a quantitative cell–cell adhesion
assay based on dispase, a protease that degrades preferentially
extracellular matrix proteins, which function as anchors of ke-
ratinocytes to the substratum (Calautti et al., 1998). Dispase
treatment of keratinocytes in low calcium medium causes de-
tachment of all cells as single cell suspension. Conversely, ke-
ratinocytes switched to high calcium medium for 9 h or
longer have formed strong cell–cell adhesions and are much
more resistant to dispase, eventually detaching from the dish
as a confluent sheet of cells. Under low calcium conditions,
dispase treatment of both control and RhoV14-expressing ke-
ratinocytes caused the expected release of all cells singly into
suspension, whereas by 9 h of calcium treatment they were
mostly resistant (Fig. 5 A). Instead, after 3 h of calcium treat-
ment only 20% of Rho-expressing keratinocytes were released
into suspension as single cells as opposed to 47% of the con-
trol. The greater resistance of Rho-expressing keratinocytes to
dispase at 3 h of calcium exposure was reduced to control lev-
els by treatment with the broad specificity tyrosine kinase in-
hibitor Genistein and the inhibitor of Src family kinases PP1
(Hanke et al., 1996; Fig. 5 B), providing a first indication that
these kinases are involved. In contrast to Genistein or PP1,
treatment with the EGF receptor inhibitor AG1478 did not
affect the dispase resistance of Rho-expressing keratinocytes
but rather increased that of control cells consistent with an en-
hancement of cell–cell adhesion by suppression of mitogenic
signals (Gumbiner, 2000). None of the indicated inhibitors
affected the expression of the virally transduced Rho V14 gene
as assessed by immunoblotting (unpublished data).
 
Activated Rho induces tyrosine phosphorylation of 
 
 
 
- 
and 
 
 
 
-catenins and p120
 
ctn 
 
independently of the 
integrity of the actin cytoskeleton
 
Underlying the above effects, activated Rho may induce
the specific tyrosine phosphorylation events connected
with the establishment of cell–cell adhesion (Calautti et
al., 1998). In fact, immunoblot analysis of E-cadherin im-
munoprecipitates showed that tyrosine phosphorylation
of 
 
 
 
- and 
 
 
 
-catenin was substantially increased in
RhoV14-expressing keratinocytes under low calcium con-
ditions to the same levels as after high calcium exposure
(Fig. 6 A).
Figure 6. Activated Rho induces tyrosine phos-
phorylation of  - and  -catenin and p120
ctn. (A) 
Keratinocytes were infected with the control 
AdGFP– -gal or AdRhoV14 adenoviruses and kept 
in low calcium medium (0) or exposed to 2 mM 
CaCl2 for the last 9 h (9 h) before termination of the 
experiment (48 h after infection). Cell extracts were 
immunoprecipitated with antibodies against E-cadherin, 
and the immune complexes were analyzed by 
sequential immunoblotting with antibodies against 
phosphotyrosine, E-cadherin,  -catenin, and 
 -catenin as indicated. The slight increase in total 
levels of  -catenin in the RhoV14-expressing 
keratinocytes was not reproducibly observed in 
other experiments (for instance in C). (B) Extracts 
from keratinocytes infected with the AdGFP– -gal 
and AdRhoV14 adenoviruses were immunoprecipi-
tated with antibodies against  -catenin (top) or p120
ctn 
(bottom) followed by sequential immunoblotting with 
antibodies against phosphotyrosine and the corre-
sponding proteins as indicated. The  -catenin 
immunoprecipitates were derived from keratinocytes 
under low calcium conditions infected with 
adenoviruses at two different multiplicity of 
infection (moi). The p120
ctn immunoprecipitates 
were from adenovirally infected keratinocytes with 
or without calcium treatment for 9 h. The slightly 
lower levels of p120
ctn tyrosine phosphorylation in 
the RhoV14-expressing keratinocytes after calcium 
treatment were not seen in other experiments. (C) 
Keratinocytes were pretreated for 1.5 h with either 
solvent alone ( ) or 1  M cytochalasin D (CD;  ) 
and either kept in low calcium medium (0) or 
exposed to 2 mM CaCl2 for 9 or 24 h. Cell lysates 
were immunoprecipitated with E-cadherin–specific 
antibodies followed by immunoblotting with anti-
bodies against phosphotyrosine and  - and  -catenin 
as indicated. (D) Keratinocytes were infected with 
either the AdGFP– -gal or AdRhoV14 adenoviruses 
and either untreated ( ) or treated with 1  M cyto-
chalasin D (CD) 12 or 24 h before termination of 
the experiment (48 h after infection). Cell lysates were analyzed as in C. Preliminary experiments showed that the indicated concentra-
tion and time of cytocalasin D treatment was sufficient to totally disrupt actin cables (as visualized by FITC-conjugated phalloidin) 
without affecting cell viability or AdRhoV14 expression. 
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p120
 
ctn
 
 associates with E-cadherin less strongly than 
 
 
 
- and
 
 
 
-catenin so that it is recovered from E-cadherin complexes
only after immunoprecipitation under low stringency condi-
tions and can best be analyzed by direct immunoprecipitation
with the corresponding specific antibodies (Calautti et al.,
1998). We found that tyrosine phosphorylation levels of
p120
 
ctn
 
, like directly immunoprecipitated 
 
 
 
-catenin, were also
substantially elevated in RhoV14-expressing keratinocytes
(Fig. 6 B). The localization of p120
 
ctn
 
 to the cell membrane is
dependent on its association with cadherins (Thoreson et al.,
2000), which is in turn positively regulated by p120
 
ctn
 
 tyro-
sine phosphorylation (Calautti et al., 1998; Anastasiadis and
Reynolds, 2000). Immunofluorescence analysis revealed that
at early times of calcium treatment RhoV14 expression en-
hanced significantly recruitment of p120
 
ctn
 
 to cell–cell junc-
tions in a tyrosine kinase-dependent manner (Fig. 7).
Expression of RhoV14 induced the expected increase in
actin cables, which could be disrupted by cytochalasin D
treatment (unpublished data). By contrast, cytochalasin treat-
ment did not block the establishment of calcium-induced
cell–cell contacts and had no effects on the induction of
 
 
 
- and 
 
 
 
-catenin tyrosine phosphorylation by either in-
creased extracellular calcium or active Rho (Fig. 6, C and D).
 
Activated Rho induces tyrosine phosphorylation of
 
 
 
- and 
 
 
 
-catenin and p120
 
ctn
 
 through a
Fyn/Src-dependent mechanism
 
We showed previously that keratinocyte differentiation is as-
sociated with induction of Fyn kinase activity (Calautti et
al., 1995), and Fyn either alone or in combination with Src
is required for 
 
 
 
- and 
 
 
 
-catenin and p120
 
ctn
 
 tyrosine phos-
phorylation (Calautti et al., 1998). Calcium treatment
induced Fyn kinase activation in control keratinocytes,
whereas no such induction was observed in cells concomi-
tantly treated with the C3 toxin (Fig. 8 A). Conversely, Fyn
kinase activity was induced by RhoV14 expression in kerati-
nocytes under low calcium conditions, whereas little or no
increase of Src activity was detected (Fig. 8 B). In parallel
with these results, treatment with the Src family kinase in-
Figure 7. Constitutively active Rho promotes recruitment of 
p120
ctn to cell–cell adhesions in a tyrosine kinase-dependent manner. 
Keratinocytes were infected with AdGFP– -gal or AdRhoV14 
adenoviruses and exposed to high calcium concentrations for the 
last 2 h (2 h) before termination of the experiment (48 h after 
infection) (top). Parallel experiments were performed with cells 
pretreated with the tyrosine kinase inhibitor Genistein (100  M) for 
1 h before calcium exposure (2 h Ca
     Gen) (bottom). Samples 
were processed for immunofluorescence analysis with anti-p120
ctn 
antibodies and FITC-conjugated secondaries as in the legend to 
Figs. 2 and 4. Samples were analyzed by confocal microscopy using 
same light exposure and image capture conditions. Images result 
from the projection of eight focal plans. Parallel analysis of kerati-
nocytes under low calcium conditions and at 9 h of calcium 
treatment yielded a pattern of staining for p120
ctn similar to that 
observed for E cadherin (as shown in Fig. 4). Bar, 20  m.
Figure 8. Rho activity is both required and sufficient for induction 
of Fyn tyrosine kinase activity. (A) Keratinocytes were pretreated for 
1.5 h with either the GST-C3 ( ) or GST proteins ( ). Cells were 
maintained under low calcium conditions or exposed to 2 mM 
CaCl2 for the indicated times and immunoprecipitated with Fyn-
specific antibodies or nonimmune IgG (N.I.) control. Half of the 
immune complexes were processed for in vitro kinase assay with 
[ -
32P]ATP without exogenous substrate (top) and half analyzed by 
immunoblotting with anti-Fyn antibodies (bottom). Positions of Fyn 
and IgG heavy chains are indicated. Densitometric scanning of the 
autoradiographs after normalization for Fyn protein amounts indi-
cated that Fyn activity as measured by the autophosphorylation 
signal was induced 3.6-fold in control cells after 6 and 9 h of 
calcium treatment, whereas in the C3-pretreated cells Fyn activity 
increased only 1.2-fold after calcium exposure. (B) Keratinocytes 
infected with control AdGFP– -gal and AdRhoV14 adenoviruses 
were immunoprecipitated with anti-Fyn or anti-Src antibodies or 
with nonimmune rabbit IgGs (N.I.) as indicated. Half of the immune 
complexes were subjected to in vitro kinase assays with [ -
32P]ATP 
and enolase as exogenous substrate (top); half of the immune com-
plexes were processed for immunoblotting with Src- or Fyn-specific 
antibodies (bottom). The enolase bands were excised from the gel, 
and their 
32P content was determined by direct scintillation count-
ing and normalized for kinase protein amounts as determined by 
densitometric scanning of the immunoblots. The ratio of Fyn kinase 
activity in Rho-expressing versus control keratinocytes was 3.2, 
whereas the ratio of Src kinase activity was 1.2. Similar results 
were obtained in three other experiments. 
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hibitor PP1 reduced tyrosine phosphorylation of 
 
 
 
- and
 
 
 
-catenin in RhoV14-expressing keratinocytes to levels sim-
ilar to the control, whereas treatment with the EGF receptor
inhibitor AG1478 had no effect (Fig. 9 A).
Primary keratinocytes derived from Fyn-deficient mice ex-
hibit a flatter morphology, lack of stratification (Calautti et
al., 1995), and suppression of 
 
 
 
- and 
 
 
 
-catenin tyrosine
phosphorylation relative to wild-type controls (Calautti et
al., 1998). RhoV14 expression in these cells induced tyro-
sine phosphorylation of 
 
 
 
- and 
 
 
 
-catenin and p120
 
ctn
 
 to a
substantially lesser extent than in wild-type controls (Fig. 9,
B and C), indicating that Fyn plays an important even if not
exclusive role in these tyrosine phosphorylation events. Our
previous work indicates that functional compensation be-
tween the Fyn and Src kinases in keratinocytes can occur
(Calautti et al., 1998), and this could also apply to media-
tion of the Rho-dependent effects. In fact, RhoV14 expres-
sion, which induced Fyn but not Src activity in wild-type
cells, induced Src activity in Fyn-negative cells (Fig. 9 D).
 
Endogenous PRK2 activity increases with keratinocyte 
differentiation and is required for establishment of cell–
cell adhesion and associated tyrosine phosphorylation
 
We showed previously that the Fyn tyrosine kinase is acti-
vated in keratinocytes by increased PKC activity (Cabodi et
al., 2000). Among the direct Rho effectors, the closely re-
lated PKN and PRK2 serine/threonine kinases share signifi-
cant homology with PKCs in their catalytic region (Bishop
and Hall, 2000). To test whether PRK2/PKN mediates the
effects of activated Rho on cell–cell adhesion, keratinocytes
were transfected with plasmid expression vectors for either
RhoV14 or the RhoV14-Y42C mutant, which is selectively
defective in PRK2/PKN binding (Sahai et al., 1998). Both
vectors also carried a green fluorescent protein (GFP)* re-
porter gene for identification of transfected cells. Trans-
fected cultures were exposed to calcium for 2 h to trigger the
initial calcium-dependent events. Immunofluorescence con-
firmed that at this early time of calcium exposure, RhoV14
expression promotes recruitment of E-cadherin to cell–cell
junctions (Fig. 10 A). Importantly, RhoV14 expression in
single isolated cells was sufficient for this effect. Unlike
RhoV14, expression of the RhoV14-Y42C mutant even in
immediately adjacent cells failed to promote recruitment of
E-cadherin to cell–cell junctions (Fig. 10 A). Transfection of
the RhoV14 and RhoV14-Y42C vectors resulted in identical
protein expression and enhanced focal adhesion formation
similarly (Fig. 10, B and C).
To test whether endogenous PRK2 and/or PKN activities in-
crease with differentiation, keratinocyte extracts were immuno-
precipitated with the corresponding antibodies followed by in
vitro kinase assays. PRK2 kinase activity was induced at 1 h of
Figure 9. Increased catenin tyrosine phosphorylation 
by activated Rho is mediated by Fyn/Src kinases. (A) 
Keratinocytes were infected for 48 h with the AdGFP–
 -gal or AdRhoV14 adenoviruses. 12 h after infection, 
cells were treated with solvent alone ( ) or with the 
AG1478 or PP1 inhibitors at the indicated concentra-
tions. Cell extracts were immunoprecipitated with 
antibodies against E-cadherin followed by immuno-
blotting with antibodies against phosphotyrosine and 
 - and  -catenin as indicated. (B) Primary keratinocytes 
derived from fyn
 / and fyn
 /  mice were infected 
with control AdGFP– -gal or AdRhoV14 adenoviruses 
at an moi of 25 and 50 (Rho 
25 and
 Rho 
50, respectively). 
Cell lysates were analyzed as in A. (C) Keratinocytes 
from fyn
 /  and fyn
 /  mice were infected with 
AdGFP– -gal and AdRhoV14 adenoviruses and 
immunoprecipitated with antibodies against p120
ctn 
followed by immunoblotting with the same antibodies 
or antibodies against phosphotyrosine as indicated. 
(D) Keratinocytes from fyn
 /  and fyn
 /  mice were 
infected with AdGFP– -gal and AdRhoV14 adenovi-
ruses as above and immuno-precipitated with anti-
bodies against Fyn or Src followed by in vitro kinase 
assays without exogenous substrates. The graph shows 
quantification of Fyn and Src activity as determined by 
densitometric scanning of the autophosphorylation 
signal after normalization for protein amounts. 
Similar results were observed by in vitro kinase 
assays in the presence of enolase as exogenous 
substrate (unpublished data).
 
*Abbreviations used in this paper: GFP, green fluorescent protein; GST,
glutathione S-transferase; moi, multiplicity of infection.  
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calcium treatment, remaining at elevated levels until at least 24 h
of high calcium exposure. The extent of PRK2 induction by
calcium was similar to that caused by RhoV14 expression (Fig.
11, A and B). PKN kinase activity was only transiently induced
at 1 h of calcium treatment and to a limited extent (Fig. 11 C).
 
Increased PRK2 expression induces catenin tyrosine 
phosphorylation and Fyn activation
 
To test whether increased PRK2 activity induces some of the
Rho effects on cell–cell adhesion, we constructed a PRK2-
expressing adenovirus. The minimal amount of the PRK2
adenovirus required to infect all keratinocytes and induce the
effects described below resulted in an approximately threefold
increase of PRK2 expression over endogenous levels (Fig. 12
A). As with cells expressing RhoV14, at early times of calcium
exposure keratinocytes infected with the PRK2 adenovirus
showed enhanced cell–cell adhesion (Fig. 12, B and C).
Tyrosine phosphorylation of 
 
 
 
- and 
 
 
 
-catenin and p120
 
ctn
 
was also induced by PRK2 overexpression (Fig. 13 A, top),
this effect being suppressed by treatment with the Fyn/Src in-
hibitor PP1 (Fig. 13 B). Immunoprecipitation of Fyn and Src
followed by in vitro kinase assay showed that Fyn but not Src
kinase activity was induced by PRK2 overexpression (Fig. 14,
A and B). Increased tyrosine kinase activity was also observed
in vitro after incubation of Fyn immunoprecipitates with a re-
combinant protein corresponding to the constitutively active
domain of PKN (highly homologous to PRK2) compared
with incubation of the same immunoprecipitates with a ki-
nase-dead mutant form of PKN (Yoshinaga et al., 1999; Fig.
14 C). A greater induction was observed with Fyn immuno-
precipitates derived from serum-starved keratinocytes versus
cells in fully supplemented medium due to higher basal levels
of Fyn activity in the latter condition.
 
Discussion
 
We have demonstrated previously that establishment of ke-
ratinocyte cell–cell adhesion is linked to increased tyrosine
phosphorylation of E-cadherin–associated catenins and
that the Fyn tyrosine kinase plays a key role in this process
(Calautti et al., 1998). Studies from another group indi-
cate that the activities of the Rac and Rho GTPases are also
essential for keratinocyte adherens junction formation
(Braga et al., 1997) similar to what has been reported for
the MDCK epithelial kidney cell line (Takaishi et al.,
1997). Here, we show that the positive function of Rho in
keratinocyte cell–cell adhesion is closely linked to down-
stream tyrosine phosphorylation events. Increased tyrosine
phosphorylation of 
 
 
 
- and 
 
 
 
-catenin and p120
 
ctn
 
 is depen-
dent on endogenous Rho function and can be triggered by
increased Rho activity. Rho activity is also required and
sufficient for Fyn kinase activation, and Fyn in turn is an
essential downstream mediator of Rho function in cell–cell
adhesion. A link between Rho and Fyn activation in con-
trol of cell–cell adhesion is provided by PRK2, a fatty acid/
Rho-dependent serine/threonine kinase with a so far elu-
sive function (Bishop and Hall, 2000).
A cross-talk between Rho GTPases and tyrosine kinases
has been implicated in several processes, including adhesion
to the substrate (Flinn and Ridley, 1996), response to mito-
genic growth factors (Belsches et al., 1997), and gene expres-
sion (Hill et al., 1995; Mao et al., 1998; Tominaga et al.,
2000). The actin cytoskeleton is a crucial mediator of the
cross-talk between Rho and Src kinases at least at the level of
adhesion to the substrate (Fincham et al., 1996; Murakami
et al., 1999). We have shown here a functional interconnec-
tion between Rho and Fyn/Src kinases also at the level of
cell–cell adhesion, which is independent of the integrity of
the actin cytoskeleton. A complex cross-regulation between
Rho and Fyn activities at the level of adherens junctions is
Figure 10. The enhanced recruitment of E-cadherin to cell–cell 
adhesions by activated Rho is dependent on PRK2/PKN binding. 
(A) Primary keratinocytes were transfected with plasmid vectors 
concomitantly expressing GFP for identification of transfected cells 
and activated RhoV14 (left) or the RhoV14-Y42C mutant (right). 2 d 
after transfection, cultures were treated with calcium for 2 h before 
fixation and processed for immunofluorescence with anti–E-cadherin 
antibodies and rhodamine red–coupled secondaries. Samples were 
analyzed by confocal microscopy using same image capture condi-
tions. Images are representative of two independent experiments in 
which a minimum of 20–30 transfected cells were analyzed for 
each condition. (B) Keratinocytes transfected with the same vectors 
as in A and maintained under low calcium conditions were 
processed for immunofluorescence with antivinculin antibodies 
for focal adhesion visualization. (C) HeLa cells were transfected 
with the same vectors as in A and B and analyzed by immunoblotting 
with antibodies against the myc-tagged Rho proteins. Bar, 20  m. 
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likely to exist. In particular, p120
 
ctn
 
 is a well-established sub-
strate for Src family kinases, and tyrosine phosphorylation of
this catenin can promote its association with E-cadherin
(Anastasiadis and Reynolds, 2000). p120
 
ctn
 
 has been impli-
cated as a negative regulator of Rho activity, and these inhib-
itory effects may be relieved by the increased association of
this catenin (through increased tyrosine phosphorylation)
with cadherin complexes (Anastasiadis et al., 2000). Our
finding that Rho activation also causes Fyn-dependent ty-
rosine phosphorylation of p120
 
ctn
 
 points to a possible posi-
tive regulatory loop between Rho and Fyn activities medi-
ated by p120
 
ctn
 
/cadherin complex formation.
Biochemical activation of a Src family kinase as a conse-
quence of increased Rho activity was not reported previ-
ously. We showed recently that PKC-
 
 
 
, a specific PKC
isoform whose expression is induced in differentiating ke-
ratinocytes, can directly cause Fyn activation (Cabodi et
al., 2000). However, the ability of activated Rho to induce
tyrosine phosphorylation of 
 
 
 
- and 
 
 
 
-catenin is not sup-
pressed by treatment with a PKC-
 
 
 
–specific inhibitor, and
tyrosine phosphorylation of these catenins is not induced by
PKC-
 
 
 
 overexpression (unpublished data). Among direct
Rho effectors, the related PKN and PRK2 kinases share sig-
nificant homology with PKC family members in their cata-
lytic domain (Bishop and Hall, 2000). We have shown that
increased PRK2 activity exerts positive effects on cell–cell
adhesion similar to those of activated Rho. However, it
causes no suppression of keratinocyte growth nor terminal
differentiation marker expression (unpublished data), which
are instead induced by PKC-
 
 
 
 activation (Cabodi et al.,
2000). Thus, although both PRK2 and PKC-
 
 
 
 induce Fyn
kinase activity their differential biological effects suggest the
existence of different pools of Fyn, which may be separately
activated by the two kinases and target different substrates.
The activities of endogenous Rho, PRK2, and PKN are
induced in keratinocytes at 1 h of calcium treatment. How-
ever, although Rho activity further increases at later times of
calcium exposure PRK2 activity remains elevated but does
not further increase, and PKN activity returns back to basal
levels consistent with a complex control of these kinases be-
sides Rho (Yoshinaga et al., 1999; Flynn et al., 2000). The
progressive increase of Rho activity starting at 1 h of cal-
cium-induced differentiation parallels that of Fyn (Calautti
et al., 1995). Thus, in addiction to persistently elevated
PRK2 activity other factors likely contribute to Fyn activa-
tion, especially at the later times. Recent studies have shown
that another class of direct Rho effectors, mDia/Formin pro-
teins (mDia-1 and -2) can associate directly with Src kinases
and change their three-dimensional conformation without
being sufficient to induce their activation (Tominaga et al.,
2000). Thus, by analogy with cooperation of multiple Rho
effectors in stress fiber formation or SRF factor activation
(Van Aelst and D’Souza-Schorey, 1997; Sahai et al., 1998) it
is possible that PKN/PRK2 and mDia-1 and -2 are concom-
Figure 11. Endogenous PRK2 activity increases 
with keratinocyte differentiation. (A) Total cell 
extracts from keratinocytes under low calcium 
conditions (0) and at various times of high calcium 
exposure were immunoprecipitated with antibodies 
against PRK2 or nonimmune IgG control ( ) and 
processed for in vitro autophosphorylation kinase 
assay with [ -
32P]ATP. Half of the immune com-
plexes were analyzed by immunoblotting with 
anti-PRK2 antibodies for normalization of kinase 
amounts (bottom). The results of three independent 
experiments are shown. Experiment 3 includes a 
parallel analysis of keratinocytes infected for 48 h 
with the AdGFP– -gal and AdRhoV14 adenoviruses. 
(B) Results were quantified by densitometric 
scanning of the autoradiographs and normalized 
for PRK2 protein amounts. Values are expressed as 
arbitrary units of kinase activity relative to basal 
levels in keratinocytes under low calcium conditions. 
Average values of PRK2 kinase activity from the 
three experiments shown in A were calculated. 
Bars refer to variation in relative kinase activity at 
the same time points among different experiments. 
(C) Total cell extracts from mouse primary kerati-
nocytes under low calcium conditions (0) and at 
various times of high calcium exposure were 
immunoprecipitated with antibodies against PKN 
or nonimmune IgG control ( ) and processed for 
in vitro autophosphorylation kinase assay with 
[ -
32P]ATP. Half of the immune complexes were 
analyzed by immunoblotting with anti-PRK2 anti-
bodies for normalization of protein amounts 
(bottom). By densitometric scanning of the autora-
diographs and normalization for PKN protein 
amounts, PKN kinase activity was found to increase 
1.8- and 1.5-fold at 1 and 2 h of calcium treatment, 
respectively, returning to basal levels thereafter.146 The Journal of Cell Biology | Volume 156, Number 1, 2002
Figure 12. Increased PRK2 activity promotes establishment of keratinocyte cell–cell adhesion. (A) Keratinocytes were infected with either 
AdGFP– -gal– or a PRK2-expressing adenovirus at 25 (AdPRK2 25) or 50 moi (AdPRK2 50). 48 h after infection cell extracts were analyzed 
by 7.5% SDS-PAGE and immunoblotting with anti-PRK2 antibodies. The position of the PRK2 protein is indicated. Densitometric analysis of 
the autoradiograph revealed an increase of 3.7- and 6-fold in PRK2 expression in cells infected with AdPRK2 at a 25 and 50 moi, respectively, 
relative to cells infected with the AdGFP– -gal virus. (B) Keratinocytes infected with the AdGFP– -gal and AdPRK2 adenoviruses were 
exposed to high calcium concentrations for 2 h before termination of the experiment (48 h after infection). Samples were processed for 
immunofluorescence analysis with anti–E-cadherin antibodies and rhodamine red–conjugated secondaries and analyzed by confocal microscopy 
using the same light exposure and image capture conditions. Each image is the projection of eight focal plans. 1 and 2 refer to images derived 
from two independent experiments. (C) Triplicate dishes of keratinocytes infected with AdGFP– -gal (white bars) or AdPRK2 (black bars) 
adenoviruses for 48 h were kept under low calcium conditions or treated with calcium for 2 h before dispase-based cell–cell adhesion assay 
(Calautti et al., 1998). Data are expressed as the percentage of single cells released by mechanical disruption after dispase treatment versus 
total number of cells recovered after subsequent treatment of the same samples with trypsin. Bar, 15  m. 
Figure 13. Expression of PRK2 induces cate-
nin tyrosine phosphorylation in a Src family–
dependent fashion. (A) Keratinocytes were 
infected with the AdGFP– -gal or AdPRK2 
adenovirus at 50 (PRK2 50) or 100 moi (PRK2 
100). 48 h after infection, cell extracts were 
immunoprecipitated with antibodies against 
E-cadherin (left) or p120
ctn (right) followed by 
immunoblotting with antibodies against phos-
photyrosine (p-Tyr; top) or  - and  -catenin 
( /  catenin; bottom left) and p120
ctn (bottom 
right). Similar results were obtained in three 
independent experiments. (B) Keratinocytes 
were infected at 100 moi with control (AdGFP–
 -gal) or PRK2-expressing (PRK2) adenoviruses. 
12 h after infection, cells were treated with solvent 
alone ( ) or the indicated concentrations of the 
PP1 inhibitor. 48 h after infection, cell extracts 
were immunoprecipitated with antibodies 
against E-cadherin followed by immunoblotting 
with antibodies against phosphotyrosine (p-Tyr; 
top) or  - and  -catenin ( /  catenin; bottom).
itantly involved in the Rho-dependent effects on catenin ty-
rosine phosphorylation and underlying Fyn activation.
Materials and methods
Cells
Primary keratinocytes were isolated from newborn Sencar mice or mice with
a disruption of the fyn gene (Stein et al., 1992) and genetically matched
wild-type controls and cultured in medium with low calcium concentration
(0.05 mM CaCl2; low calcium medium) as described previously (Calautti et
al., 1998). The dispase-based cell–cell adhesion assay was as described pre-
viously (Calautti et al., 1998). Bacterially expressed C3 transferase toxin or
glutathione S-transferase (GST) control proteins were purified according to
Dillon and Feig (1995) and delivered into the cells by osmotic shock (Okada
and Rechsteiner, 1982). Briefly, cells were incubated for 30 min in 10% PEG
8000, 0.5 M sucrose in low calcium medium without serum, and EGF in the
presence of 30  g/ml of either GST control or GST-C3 proteins followed by
incubation in hypotonic medium (60% serum/EGF-free low calcium me-Fyn mediates Rho function in cell–cell adhesion | Calautti et al. 147
dium; 40% H2O) for 2 h at 34 C. This medium was replaced with the origi-
nal medium supplemented with 20 mM Hepes (pH 7.4). After 1.5 h to allow
recovery, some cultures were exposed to calcium (2 mM) for an additional
9 h. More than 85% of cells assumed GST fusion proteins as assessed by im-
munofluorescence with anti-GST antibodies (unpublished data).
Plasmid expression vectors and recombinant adenoviruses
Human cDNAs for the myc-tagged RhoV14 and RhoV14 Y42C mutants
(Sahai et al., 1998) and for Flag-tagged wild-type PRK2 (Vincent and Settle-
man, 1997) were subcloned into the pAdTrack-CMV expression vector,
which already carries a cDNA for the GFP for replication-defective aden-
oviruses generation (He et al., 1998). Conditions for infection of kerati-
nocytes were as reported previously (Cabodi et al., 2000).
Antibodies
Monoclonal antibodies against E-cadherin (clone 36),  -catenin,  -cate-
nin, pp120
ctn, Fyn, PRK2, PKN, polyclonal antibodies against SHC, and
HRP-conjugated antiphosphotyrosine antibodies (RC20H) were from
Transduction Laboratories. Polyclonal antibodies against Fyn (Fyn3), Src
(SRC-2) and RhoA, anti-RhoA and anti–c-Myc (9E10) monoclonal antibod-
ies, and affinity purified rabbit and mouse IgGs were from Santa Cruz Bio-
technology, Inc. Antivinculin monoclonal antibodies were from Sigma-
Aldrich, and anti-Src M327 monoclonal antibodies were from Oncogene
Research Products. FITC-conjugated antiphosphotyrosine monoclonals
4G10 were from Upstate Biotechnology.
Immunoprecipitations, kinase assays, and pull-down assays
Conditions for immunofluorescence, immunoprecipitation, immunoblot-
ting, and in vitro kinase assays were as described previously (Calautti et
al., 1995, 1998). GST fusion proteins encompassing the constitutively ac-
tive PKN kinase domain (543–942 amino acids) and the corresponding ki-
nase-dead version (PKN 543–942 K644E) were produced and purified as
described previously (Yoshinaga et al., 1999). Fyn immunoprecipitates in
kinase buffer (20 mM Tris-HCl, pH 7.5, 4 mM MgCl2) were divided into
two aliquots and incubated with either glutathione-Sepharose beads
bound to 20 ng kinase-active GST-PKN or its kinase-dead version (K644E)
in 50  l of kinase buffer supplemented with 100  M cold ATP. After 30
min at 30 C, samples were diluted into 1 ml of NP-40 lysis buffer, and after
washes to remove unincorporated ATP they were incubated for 5 min at
30 C in 50  l of Fyn kinase buffer (20 mM Hepes, pH 7.4, 5 mM MgCl2, 3
mM MnCl2) supplemented with 10  g of poly Glu-Tyr, 1  M ATP, and 5
 Ci of [ -
32P]ATP (6,000 Ci/mM). Pull-down assays with the GST-Rhotekin
Rho binding domain coupled to glutathione-agarose beads (Upstate Bio-
technology) were performed as described (Ren and Schwartz, 2000).
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